Latest News - IDEXX Laboratories

Top Corporates Hub

IDEXX Laboratories

IDXX | NASDAQ | United States
538
-78
Rank
$39.43B
Market Cap
$3.89B
+$ 0.23B
+6.28%
Revenue
$0.87B
Earnings
11K
Employees
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average

29.08.2025 13:35

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

Read More

Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock

22.08.2025 13:50

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More

National Veterinary Associates Welcomes Brian McKeon to Board of Directors

18.08.2025 13:30

National Veterinary Associates (NVA) is pleased to announce the appointment of Brian McKeon to its Board of Directors. McKeon brings a wealth of expertise in finance and strategic planning, having held leadership roles at multiple publicly traded corporations.

Read More

Piper Sandler Raises IDEXX Laboratories (IDXX) PT to $700, Cites Strong Q2 Results

13.08.2025 19:12

IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best performing S&P 500 stocks to buy now. On August 11, Piper Sandler raised the firm’s price target on Idexx Laboratories to $700 from $510 following the company’s Q2 2025 financial results. The firm kept a Neutral rating on the shares. IDEXX Laboratories reported total revenues of […]

Read More

Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today

12.08.2025 12:30

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Read More

Why a Company You’ve Never Heard of Is One of the Best Nasdaq-100 Stocks of the Year

06.08.2025 11:30

Going under the radar, shares of this vet tech company have been winners this year.

Read More

Excellent Execution Drove IDEXX Laboratories (IDXX) Shares Amid Macro Challenges

31.07.2025 13:07

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% (Institutional Shares) in the quarter, against a challenging backdrop for the broader Health Care sector, compared to a 6.19% decline for the Russell 3000 Health Care […]

Read More

Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates

31.07.2025 11:10

Integra (IART) delivered earnings and revenue surprises of +4.65% and +5.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Read More

Should You Consider Adding IDEXX Laboratories (IDXX) to Your Portfolio?

22.07.2025 14:39

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The market sentiment shifted in the second quarter, from a sharp decline to a V-shaped recovery. In the second quarter, the strategy returned 9.36% (gross) and 9.15% (net) compared […]

Read More

IDEXX Laboratories, Inc.(NasdaqGS: IDXX) dropped from Russell 1000 Dynamic Index

30.06.2025 04:46

IDEXX Laboratories, Inc. dropped from Russell 1000 Dynamic Index...

Read More

IDEXX Laboratories to Release 2025 Second Quarter Financial Results

24.06.2025 13:01

IDEXX Laboratories, Inc. , a global leader in pet healthcare innovation, has scheduled the release of its 2025 second quarter financial results for Monday, August 4, 2025, before the market opens. The...

Read More

IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners

17.06.2025 06:24

IDEXX Laboratories Inc. (NASDAQ:IDXX) is among the 12 best healthcare stocks. On June 11, Leerink Partners analyst Daniel Clark reiterated an Outperform rating on the stock. However, the analyst increased his stock price target to $580 from $515. According to the analyst IDEXX Laboratories has evolved to become the largest player in the veterinarian space. […]

Read More

IDEXX Laboratories (NasdaqGS:IDXX) Launches Catalyst Cortisol Test for Canine Health

05.06.2025 17:17

IDEXX Laboratories (NasdaqGS:IDXX) recently introduced its Catalyst® Cortisol Test, an advance in veterinary diagnostics, and reported an earnings growth with a raised revenue guidance for 2025. Furthermore, the company repurchased 930,800 shares, indicating strong financial health. These developments likely supported IDEXX's 22% share price increase over the last quarter. Meanwhile, broader market movements were relatively modest, with indices experiencing slight gains amid optimistic trade...

Read More

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

05.06.2025 11:00

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst® Cortisol Test, which measures real-time quantitative cortisol concentrations to support the diagnosis of Addison's disease and diagnosis and management of Cushing's syndrome in dogs. IDEXX's Catalyst Cortisol Test is the third menu expansion in under a year for the Catalyst platform, further advancing the diagnostic capabilities available to veterinary practices at t

Read More

IDEXX Laboratories, Inc. Announces the Launch of the Catalyst®? Cortisol Test

05.06.2025 08:06

IDEXX Laboratories, Inc. announced the launch of the Catalyst®? Cortisol Test, which measures real-time quantitative cortisol concentrations to support the diagnosis of Addison's disease and...

Read More

Idexx Laboratories - Launches Catalyst Cortisol Test For Diagnosing Addison's Disease And Managing Cushing's Syndrome In Dogs

05.06.2025 07:22

IDEXX Laboratories Inc: * IDEXX LABORATORIES - LAUNCHES CATALYST CORTISOL TEST FORDIAGNOSING ADDISON'S DISEASE AND MANAGING CUSHING'S SYNDROME INDOGSSource text:Further company...

Read More

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

05.06.2025 07:01

The Catalyst® Cortisol Test provides veterinarians with real-time critical insights when evaluating dogs for Addison's disease and Cushing's syndromeWESTBROOK, Maine, June 5, 2025 /PRNewswire/ --...

Read More

Weitz Multi Cap Equity Fund Q1 2025 Commentary

30.05.2025 09:24

The Multi Cap Equity Fund’s Institutional Class returned +0.81% for the quarter, comparing favorably to the Russell 3000 Index’s loss of -4.72%.

Read More

If You Invested $1000 in Idexx Laboratories a Decade Ago, This is How Much It'd Be Worth Now

19.05.2025 12:30

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Read More